SB
This biopharmaceutical company develops therapies that modulate the gut microbiome to enhance the safety and efficacy of cancer immunotherapy. Their focus is on improving treatment outcomes and quality of life for oncology patients. The goal is to enable more patients to achieve a durable response to existing cancer treatments.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This biopharmaceutical company develops therapies that modulate the gut microbiome to enhance the safety and efficacy of cancer immunotherapy. Their focus is on improving treatment outcomes and quality of life for oncology patients. The goal is to enable more patients to achieve a durable response to existing cancer treatments.